IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
Pre-Market: 20:00
IDEAYA Biosciences Debt to Equity Ratio : 0.0244 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0244 |
| March 31, 2026 | 0.0305 |
| December 31, 2025 | 0.0273 |
| September 30, 2025 | 0.0249 |
| June 30, 2025 | 0.0277 |
| March 31, 2025 | 0.0254 |
| December 31, 2024 | 0.0181 |
| September 30, 2024 | 0.0159 |
| June 30, 2024 | 0.002 |
| March 31, 2024 | 0.0026 |
| December 31, 2023 | 0.0046 |
| September 30, 2023 | 0.0041 |
| June 30, 2023 | 0.0051 |
| March 31, 2023 | 0.0091 |
| December 31, 2022 | 0.01 |
| September 30, 2022 | 0.0106 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0162 |
| March 31, 2022 | 0.0165 |
| December 31, 2021 | 0.0172 |
| September 30, 2021 | 0.0176 |
| June 30, 2021 | 0.0249 |
| March 31, 2021 | 0.0272 |
| December 31, 2020 | 0.0339 |
| September 30, 2020 | 0.0363 |
| June 30, 2020 | 0.0361 |
| March 31, 2020 | 0.0729 |
| December 31, 2019 | 0.0675 |
| September 30, 2019 | 0.0638 |
| June 30, 2019 | 0.0617 |
| March 31, 2019 | 0.0964 |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Xencor, Inc. | 0.338 |
| BioMarin Pharmaceutical, Inc. | 0.6672 |
| MediciNova, Inc. | 0.0031 |
| Viking Therapeutics, Inc. | 0.01 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.310B |
| Total Liabilities (Quarterly) | 110.79M |
| Shareholders Equity (Quarterly) | 1.199B |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | -0.02% |